FDA attacks American Red Cross for blood violations

by Medindia Content Team on  December 14, 2001 at 2:41 PM General Health News
RSS Email Print This Page Comment
FDA attacks American Red Cross for blood violations
The Food and Drug Administrations asked a federal judge to hold the American Red Cross in contempt of court for repeated safety violations in its blood collection program. FDA is acting today to ensure that the Red Cross takes much more seriously its role as guardian of the safety of the nation's blood supply, which is essential to the public health.

Despite a promise made by the Red Cross in a 1993 consent decree to make substantial improvements in the quality control of its blood program, inspections over the past two years have revealed persistent and serious violations of blood safety rules.

FDA inspectors said they found several violations including incorrect labeling and release of potentially contaminated blood, a lack of adequate quarantine and inventory controls and inadequate donor registration controls. The FDA wants the court to grant it the power to levy fines of $10,000 a day as well as for each future safety violation inspectors discover.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Blood Group Thalassemia Blood in Stools - Symptom Evaluation Bombay Blood Group 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive